Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

532-43-4

Thiamine Nitrate

532-43-4
137330-13-3

Tilmicosin phosphate

137330-13-3
10161-34-9

Trenbolone acetate

10161-34-9
64603-91-4

THIP

64603-91-4
481-21-0

5alpha-Cholestane

481-21-0
951-55-3

5-Methyl-DL-tryptophan

951-55-3
220620-09-7

Tigecycline

220620-09-7
NA

Tolylfluanide-d7

NA
55297-95-5

Tiamulin

55297-95-5
1916-07-0

Trimethoxybenzoate methyl 3,4,5

1916-07-0
54965-24-1

Tamoxifen Citrate

54965-24-1
92051-23-5

Mannose Triflate

92051-23-5
97240-79-4

Topiramate

97240-79-4
51115-67-4

2-Isopropyl-N,2,3-trimethylbutanamide

51115-67-4
136-47-0

Tetracaine Hydrochloride

136-47-0
57-13-6

Urea USP

57-13-6
5006-64-4

2-Fluoro-3-ureidopropionic Acid

5006-64-4
1404-93-9

Vancomycin HCl

1404-93-9
143-67-9

Vinblastine sulfate

143-67-9
2068-78-2

Vincristine sulfate

2068-78-2